Associations between informal care costs, care quality, carer rewards, burden and subsequent grief:the international, access, rights and empowerment mortality follow-back study of the last 3 months of life (IARE I study) by Higginson, Irene J et al.
                          Higginson, I. J., Yi, D., Johnston, B. M., Ryan, K., McQuillan, R.,
Selman, L., Pantilat, S. Z., Daveson, B. A., Morrison, R. S., &
Normand, C. (2020). Associations between informal care costs, care
quality, carer rewards, burden and subsequent grief: the international,
access, rights and empowerment mortality follow-back study of the
last 3 months of life (IARE I study). BMC Medicine, 18, [344 (2020)].
https://doi.org/10.1186/s12916-020-01768-7
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s12916-020-01768-7
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMC at
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01768-7 . Please refer to any applicable
terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
RESEARCH ARTICLE Open Access
Associations between informal care costs,
care quality, carer rewards, burden and
subsequent grief: the international, access,
rights and empowerment mortality follow-
back study of the last 3 months of life
(IARE I study)
Irene J. Higginson1,2* , Deokhee Yi1*, Bridget M. Johnston3, Karen Ryan4, Regina McQuillan5, Lucy Selman1,6,
Stephen Z. Pantilat7, Barbara A. Daveson1, R. Sean Morrison8 and Charles Normand1,3
Abstract
Background: At the end of life, formal care costs are high. Informal care (IC) costs, and their effects on outcomes,
are not known. This study aimed to determine the IC costs for older adults in the last 3 months of life, and their
relationships with outcomes, adjusting for care quality.
Methods: Mortality follow-back postal survey.
Setting: Palliative care services in England (London), Ireland (Dublin) and the USA (New York, San Francisco).
Participants: Informal carers (ICrs) of decedents who had received palliative care.
Data: ICrs reported hours and activities, care quality, positive aspects and burdens of caregiving, and completed the
Texas Revised Inventory of Grief (TRIG).
Analysis: All costs (formal, informal) were calculated by multiplying reported hours of activities by country-specific
costs for that activity. IC costs used country-specific shadow prices, e.g. average hourly wages and unit costs for nursing
care. Multivariable logistic regression analysis explored the association of potential explanatory variables, including IC costs
and care quality, on three outcomes: positive aspects and burdens of caregiving, and subsequent grief.
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Results: We received 767 completed surveys, 245 from London, 282 Dublin, 131 New York and 109 San Francisco. Most
respondents were women (70%); average age was 60 years. On average, patients received 66–76 h per week from ICrs for
‘being on call’, 52–55 h for ICrs being with them, 19–21 h for personal care, 17–21 h for household tasks, 15–18 h for
medical procedures and 7–10 h for appointments. Mean (SD) IC costs were as follows: USA $32,468 (28,578), England $36,
170 (31,104) and Ireland $43,760 (36,930). IC costs accounted for 58% of total (formal plus informal) costs. Higher IC costs
were associated with less grief and more positive perspectives of caregiving. Poor home care was associated with greater
caregiver burden.
Conclusions: Costs to informal carers are larger than those to formal care services for people in the last three months of
life. If well supported ICrs can play a role in providing care, and this can be done without detriment to them, providing
that they are helped. Improving community palliative care and informal carer support should be a focus for future investment.
Keywords: Informal care, End of life, Costs of care, Mortality follow-back survey, Grief, Carer burden
Background
In palliative care, those important to the patient, such as
family members and informal carers (hereafter called ‘in-
formal carers’, ICrs) are part of the unit of care. ICrs
often provide high levels of demanding care and support
willingly, because they see this as part of their relation-
ship with the patient and are ambivalent to considering
their own needs [1]. While some ICrs report positive
outcomes such as closer relationships with others,
greater appreciation of life, increased empathy and posi-
tive self-view, many can experience anxiety, depression,
decline in quality of life and/or post-traumatic stress
disorder [2]. Patient symptoms, such as breathlessness,
fatigue or cognitive impairments, and advanced illness
can increase caregiver burden and/or reduce caregiver
rewards [3–6]. However, this research is usually based
on small, single setting studies [3–6].
Formal care costs in the last year of life account for
between 10 and 25% of health care costs [7–10], but to
the best of our knowledge, informal care costs have
never been compared internationally. Their costs are
much less recognised or understood [11]. Systematic
review evidence indicates that living with relatives and/
or extended family support doubles or more (up to 7.8
times) the odds of patients being able to be cared for
and to die at home, something for which many people
wish [12]. The activities of ICrs likely save states billions
in health and social care spending each year [13]. Home
palliative care is thought to be cost-effective [14, 15].
But what are the costs for ICrs? Dying at home when
preferred can often require informal caregivers to be
given time off work [16], which is unpaid. The relation-
ship of IC costs with the outcomes for carers, such as
burden, or subsequent grief are not known.
Therefore, as part of the International, Access, Rights,
and Empowerment (IARE I) study of palliative care in
three countries, we aimed to determine and compare the
informal care (IC) costs and their associations with self-
reported caregiver burden, rewards and subsequent




We conducted a mortality follow-back postal survey of
key informants (normally relatives and informal carers)
of decedents identified by palliative care services in
participating hospitals. Reporting follows STROBE
[17] and MORECARE statements [18]. See declara-
tions for ethical approvals. Further details are pro-
vided elsewhere [19].
Settings
Three countries included are in the top 10 (of 80 countries)
of the Economist Intelligence Unit Quality of Death Index;
rankings (scores) are as follows: England − 1 (93.9), Ireland
− 4 (85.8) and the USA − 9 (80.8) [20]. This index ranks the
quality of palliative and end of life care across the world ac-
cording to predetermined criteria, national data and inter-
views. The countries had different health care systems
(England: National Health Service; Ireland: National Health
Insurance; USA: Private Health System, palliative care cov-
ered by most insurance agencies and Medicare and Medic-
aid [21]) and philanthropy supporting hospice and palliative
care [22]. Participating palliative care services in London
(England), Dublin (Ireland), New York and San Francisco
(USA) were as follows: established hospital palliative care
consulting teams in all countries, a hospital-based commu-
nity outreach team in London and an inpatient palliative
care ward in New York. Details of the participating services
are found elsewhere [19, 23, 24].
Inclusion criteria
We identified patients aged ≥ 65 years who had accessed
(≥ 1 contact) a participating palliative care team and died
4–10 months prior to the survey date. Their next of kin,
as indicated in clinical records, was sent study informa-
tion and a postal questionnaire from their clinical service
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(following data-protection regulations), with a pre-paid
envelope addressed to the research team. The next of kin
was asked to complete the questionnaire or pass it to the
most appropriate individual who was close to the patient
for completion. All data were analysed anonymously.
Questionnaire and data collection
Consenting respondents returned a self-completed ques-
tionnaire, pre-piloted in all countries. Respondents reported
demographic data including socio-economic status, living
arrangements and relationship to patient and the patient’s
illnesses. This was supplemented by patient record data on
age, diagnosis and co-morbidities. In addition, ICrs re-
ported health and social care services used by patients in
the last 3 months of life.
Informal time spent caring was counted with the
Client Service Receipt Inventory (CSRI) [19, 23], by ask-
ing respondents to document all IC time spent by family
and friends as well as the respondents during the last
3 months of the patient’s life. Six questions covered a
wide range of possible physical, social, emotional and
other caring activities, including time spent ‘on call’ and
being available for the patient (Additional file 1: Table
S1). Answers were given as categories of hours per week:
less than 5 h, 5–9 h, 10–19 h, 20–49 h, 50 or more hours
and all the time.
Quality of care of the last place of stay (e.g. hospital,
home) in the last 3 months was rated using Likert scales
from 1 (very poor) to 6 (excellent).
Carer burden and positive aspects of caregiving (PAC)
at the time when patients died was measured according
to the ZARIT 12 [25, 26] and a set of eight questions
derived from previous studies, respectively [4, 27, 28].
Subsequent grief was assessed using the revised Texas
Revised Inventory of Grief (TRIG). This measures the
intensity of grief after the death of a close person and
has two scales: TRIG I (past behaviours when patient
died, eight items) and TRIG II (present feelings, referred
to as subsequent grief in this study, 13 items) [29–31].
Analysis
Hours of IC spent per week for each item were con-
verted as the middle point of the given range: 2.5 for less
than 5 h, 7 for 5–9 h and 15, 30, 50 and 112 for the rest.
To determine the IC costs for each patient, we multi-
plied the number of hours of care with country-specific
shadow prices such as average hourly wages and unit
costs for nursing care. All costs were translated into
USD ($) for comparison, using the purchasing power
parity (PPP) index. We checked the summary statistics
and plotted the informal cost distributions of all patients
in each country for illustrative purposes.
Formal care costs were extracted from an earlier analysis
on this dataset and are presented to aid interpretation.
These were calculated by multiplying the quantity of spe-
cific services used according to the CSRI with correspond-
ing country-specific unit costs [19].
Descriptive analyses
We described provision and hours of IC by country. We
explored the distribution of formal health and social care
costs (in $1000) and IC costs (in $1000) and calculated
the proportion of IC costs in the total societal costs. We
also described the IC costs by carers’ relationship to the
patients. After examining the distribution of subsequent
grief, carer burden and PAC by country and carer’s
relationship to the patient, we plotted the univariate
relationship between these variables and IC costs.
Regression analyses
We examined the factors associated with subsequent
grief, carer burden and PAC using multiple regression
analysis. We selected explanatory variables based on pre-
vious literature reviews, meta-analysis and theoretical
considerations [2, 32, 33]. These included age, gender,
patient’s cause of death (cancer or not), carer’s relation-
ship to patient, a religious faith of carer, carer’s feeling
about household financial status, carer’s quality rating
with care at hospital or home and informal and formal
care costs. Country fixed effects were also included in
the models. We used complete cases only.
Sample size
We calculated the sample size based on being able to de-
tect a difference in the mean IC costs between countries,
with 80% of power and α = 0.05 (0.025 with Bonferroni
correction for two pairs of comparison), which would
require 229 individuals in each country.
Results
Sample characteristics
We received 767 completed surveys: 245 (32.4%) of 756
delivered surveys in London, 282/580 (48.6%) in Dublin,
131/548 (23.9%) in New York and 109/342 (31.9%) in
San Francisco. Missing values were infrequent (2–5% of
variables), if any, and scattered with no patterns.
Carers
Most respondents were women (70%) and average age
was 60 years (Table 1). 34.7% of all respondents were
daughter of patients, followed by wife or female partner
(22.4%), husband or male partner (12.3%) and son
(11.7%). In Ireland, 92.6% of respondents had a religious
belief, which is higher than in the UK (82.6%) and the
USA (79.9%). About 2/3 were living comfortably or
doing alright regarding the household income of them-
selves. More carers were in paid employment in the
USA (52.4%) than in the UK (35.3%) or Ireland (43.6%).
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Table 1 Characteristics of the deceased patients and respondents (bereaved carer) (unit: %, mean (s.d.))
London (N = 245) Ireland (N = 282) USA (N = 240) All (N = 767)
Bereaved carer
Women (n = 749) 72.6% 67.9% 70.9% 70.4%
Age (n = 738) 61.6(12.6) 59.2(13.7) 60.9(14.1) 60.5(13.5)
Ethnicity (= 1 if white) (n = 725) 85.2% 100.0% 59.3% 82.5%
Employment status (n = 730)
Employed and paid 35.3% 43.6% 52.4% 43.7%
Employed and unpaid 8.5% 13.6% 8.7% 10.4%
Unemployed 8.9% 9.1% 6.5% 8.2%
Retired 47.2% 33.7% 32.5% 37.7%
Relationship (n = 742)
Wife or female partner 22.1% 20.5% 27.4% 22.4%
Husband or male partner 12.1% 11.9% 14.1% 12.3%
Daughter 37.5% 38.4% 31.2% 34.7%
Son 9.6% 16.0% 10.3% 11.7%
Female other 8.8% 7.1% 8.6% 7.8%
Male other 2.5% 4.5% 2.6% 3.1%
Others 7.5% 1.5% 6.0% 4.7%
Household income (n = 750)
Living comfortably 31.0% 19.2% 45.4% 31.2%
Doing alright 37.6% 44.3% 32.5% 38.5%
Just about getting by 9.8% 16.3% 8.8% 11.9%
Finding it quite difficult 9.4 10.6% 3.8% 8.1%
Finding it very difficult 2.5% 0.7% 0.8% 1.3%
Do not know 2.5% 2.5% 4.2% 3.0%
Religious belief (= 1 if yes) (N = 729) 82.6% 92.6% 79.9% 85.5%
ZARIT
Burden1) (N = 734) 25.1(8.8) 23.6(9.4) 24.6(8.7) 24.4(9.0)
Positive aspects of caregiving2) (N = 729) 29.2(6.9) 30.0(7.4) 30.7(6.7) 30.0(7.1)
TRIG
Past behaviour (N = 734) 20.5(8.9) 21.7(8.3) 20.1(7.4) 20.8(8.3)
Subsequent feeling (N = 738) 3) 43.0(13.8) 44.7(13.1) 41.1(12.0) 43.0(13.1)
Patient
Women 54.3% 51.4% 52.9% 52.8%
Age (years) (n = 766) 79.7(8.3) 80.8(8.2) 78.5(9.1) 79.7(8.6)
65–69 13.9% 12.8% 21.7% 15.9%
70–79 36.3% 29.9% 32.9% 32.9%
80–89 36.3% 41.6% 33.3% 37.3%
90–102 13.5% 15.7% 12.1% 13.8%
Diagnosis (n = 763)
Lung and respiratory cancer 13.5% 11.4% 7.9% 11.0%
Breast cancer 2.0% 3.9% 2.9% 3.0%
Genitourinary cancer 12.7% 7.5% 5.8% 8.6%
Lymphatic cancer 10.2% 5.7% 5.8% 7.2%
Digestive cancer 12.2% 10.3% 12.1% 11.5%
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Subsequent grief was the summation of 13 items of
TRIG, with mean scores of 20.8 (SD 8.3) and 43.0 (SD
13.1). Mean scores of ZARIT 12 measuring carer’s bur-
den were 24.4 (SD 9.0). Positive aspects of caregiving
(PAC) were measured using 8 items and its mean score
was 30.0 (SD 7.1).
Patients
The average age of those who had died was 80 years, with
similar numbers of women and men (Table 1). Patients
had on average 2–3 ICrs; 68% had an ICr living with them;
49% had cancer as a cause of death. Health and social care
costs were on average $27,452 (SD $28,203), highest in
the USA ($37,327) and lowest in the UK ($15,756).
Hours of informal care (IC)
The most common care giving activities in all coun-
tries were spending time with the patient (82–89%
of patients received this) and ‘being on call’ (78–81%
of patients received this), i.e. being there to watch
for problems at least a few hours per week (Table 2).
Household tasks were provided to 67–69% of pa-
tients. More than half of the patients were helped
with personal care and medical procedures. On aver-
age, patients received 19–21 h of IC per week from
friends or family for personal care, 15–18 h for med-
ical procedure, 7–10 h for appointments and 17–21 h
for household tasks. Friends and/or family spent 66–
76 h per week on being on call and 52–55 h with
patients.
Table 1 Characteristics of the deceased patients and respondents (bereaved carer) (unit: %, mean (s.d.)) (Continued)
London (N = 245) Ireland (N = 282) USA (N = 240) All (N = 767)
Ill-defined cancer 6.1% 3.9% 0% 3.4%
Other cancer 2.9% 5.0% 4.2% 4.0%
Non-cancer respiratory 7.4% 16.0% 9.2% 11.1%
Non-cancer circulatory 14.7% 16.7% 26.3% 19.0%
Non-cancer CNS4) 10.2% 7.1% 2.9% 6.8%
Renal failure 1.2% 3.2% 6.7% 3.7%
Other non-cancer4) 5.7% 9.2% 16.3% 10.3%
Primary carer (= 1 if available) (n = 731) 87.6% 87.1% 92.2% 88.8%
Living with (= 1 if yes) (n = 746) 61.4% 67.9% 75.2% 68.1%
Religious belief (= 1 if religious) 88.1% 98.5% 84.6% 90.8%
Number of carers (n = 731) 2.5(1.8) 3.0(2.0) 2.6(1.7) 2.7(1.9)
Health and social care costs (USD) 15,756(15,036) 29,210(24,231) 37,327(37,234) 27,452(28,203)
Twelve items had scales from 0 to 4 (0 never; 1 rarely; 2 sometimes; 3 quite frequently; 4 nearly always), and the range of total scores is 0 to 48. Higher score
means more distressful burden
Eight items had scales from 0 to 4 (0 never; 1 rarely; 2 sometimes; 3 quite frequently; 4 nearly always), and the range of total scores is 0 to 32. Higher score
means more positive feeling about caregiving experience
Revised Texas Revised Inventory of Grief. Past behaviour and subsequent grief sums 8 and 13 items respectively where each item was measured in Likert scale
(1 completely true to 5 completely false). Higher scores are indicative of less psychological distress
Non-cancer CNS included Alzheimer’s dementia, Parkinson’s related disorders, motor neurone disease, multiple sclerosis and other neurological diseases. Note that
some people with dementia may have been coded as ‘other non-cancer’
Table 2 Number (percentage) of patients in the last 3 months of life who received informal care (IC) support according to main
categories in the CSRI questionnaire, and the mean (SD) hours provided per week provided by ICrs for each of these activities
England (N = 245) Ireland (N = 282) USA (N = 240)
n Mean s.d. n Mean s.d. n Mean s.d.
Personal care 141 57.6% 19.12 18.62 163 57.8% 21.02 18.64 131 54.6% 18.59 17.65
Medical procedure 135 55.1% 17.02 18.03 154 54.6% 18.49 18.77 135 56.3% 15.05 16.61
Appointments 170 69.4% 7.57 10.54 190 67.4% 7.30 10.47 164 68.3% 9.82 11.75
Household task 182 74.3% 21.24 17.55 190 67.4% 20.88 17.63 168 70.0% 16.72 15.52
On call 199 81.2% 76.00 46.12 221 78.4% 72.83 46.63 187 77.9% 66.23 48.48
Time with patient 201 82.0% 54.88 47.12 251 89.0% 53.02 46.38 206 85.8% 51.94 45.75
Notes: The questions used in the questionnaires were as follows: Did you and other friends or family help with (1) personal care? (e.g. washing, dressing), (2)
medical procedures? (e.g. taking medicines), (3) going to appointments or treatments?, (4) household tasks? (e.g. shopping, cooking), (5) time spent on call (i.e.
being with her/him if needed) and (6) time spent with her/him (e.g. visiting, doing things together)
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Informal care (IC) costs versus formal care costs and by
relationship to patient
Median IC costs in the last 3 months of life were $28,
847 (USA), $31,192 (England) and $36,930 (Ireland),
with right skewed distributions that were similar for all
countries (Fig. 1, Table 3, Additional file 1: Figure S2
and Figure S3). Removing the being on call element of
IC cost estimates reduced the costs, although the distri-
butions remained unchanged (Fig. 1, Table 3, Additional
file 1: Figure S2 and Figure S3). IC costs varied less than
did formal care costs between countries (Table 3). IC
costs were not associated with total formal care costs
(Pearson’s r = − 0.0057), nor with hospice/palliative care
costs (Pearson’s r = 0.0608).
IC costs were higher for husband/male partners ($48,
679) and wife/female partners ($43,729) than those of
daughters/sons or other relatives/others (Additional file 1:
Table S1).
Carer burden, positive aspects of caregiving (PAC),
subsequent grief and informal care costs
Subsequent grief, carer burden and PAC were near nor-
mally distributed and were similar across the three
countries (Additional file 1: Figure S1). Wives, husbands
and daughters reported higher subsequent TRIG grief
score than other relatives, implying lesser distress
(Additional file 1: Table S2). Burden felt by carers
was slightly higher among daughters and sons than
others. Positive aspects of caregiving did not differ by
the relationship to patient much except the male
relatives.
In all three countries, there was a consistent pattern
that subsequent grief was positively associated with IC
costs, implying that more time spent on caring for pa-
tients was associated with lesser distress felt afterwards
(Fig. 2).
Multiple regression analysis
As for the univariate analysis, higher IC costs were asso-
ciated with higher TRIG scores for subsequent grief, in-
dicative of less grief (models 1 and 2, Table 4). However,
the coefficients were small and the effects varied be-
tween individuals. For older patients, the carer’s subse-
quent grief score was lower, i.e. the carer grieved more.
Higher IC costs were also associated with higher
scores for PAC (models 5 and 6, Table 2). Higher carer’s
satisfaction with home care was associated with higher
PAC.
IC costs were not associated with caregiver burden.
Satisfaction with home care was negatively associated
with caregiver burden, i.e. carers felt more burdened
when they felt care provided for patients was not satis-
factory (model 4, Table 4). Carers with a religious faith
felt less burdened. Daughters felt more burdened, com-
pared to wife/female partner of patients.
Discussion
This is the first international study of ICrs of older
people in their last 3 months of life. We found that IC
costs were high ($37,802), representing 58% of total soci-
etal costs. Even when the elements of being on call are
removed, IC costs still account for 46% of total care
costs. Those carers who reported higher IC costs, and/or
more hours of informal care, had lesser subsequent grief
and reported more positive aspects of caregiving, with-
out a negative effect on caregiver burden. Quality of
care, as reported by the carer, was an important medi-
ator; poorer experiences with home care were associated
with more caregiver burden and fewer positive aspects
of caregiving.
The inverse relationship between IC costs and subse-
quent grief surprised us. It appears that providing more
hours of IC to patients protected the carer during
Fig. 1 Distribution of costs of informal care (IC) provided for older patients in their last 3 months of life, with and without ‘time being on call’ in
three countries
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bereavement, although the effect was small and varied.
More hours of IC also led to a more positive feelings
about caregiving. It may be that providing support pro-
tected ICrs from guilt in later bereavement. It may also
be that more hours of IC support were provided by
larger families and groups, and so the ICrs were not
required to do so much individually, and possibly also
gained from mutual support from other family members
and friends. Other possible explanations include the fol-
lowing: that ICrs providing more support were more
prepared for the death and ensured that the person they
cared for did not feel burden to others; both factors pos-
sibly protect against complicated grief [34]. This finding
needs more study, widening the usual approach of con-
sidering ‘single’ patient-family dyads. However, it is a
promising development, as it suggests that ICrs can and
often do want to be part of the caring team—and that
this can be done without being harmful to them; they
just need help to allow them to do this well. This finding
should also inform the development of caregiver support
interventions [35], which need to provide support across
changes in setting [36]. Our finding did not support
other meta-analyses that higher number of hours spent
caregiving led to higher caregiver burden [32], and we
suggest that this difference is because other studies did
not account for variations in care quality and other
potential confounders.
Poor formal home care quality was associated with
poorer ICr outcomes, in terms of greater burden and
fewer rewards. Poor quality of end-of-life care has been
associated also with complicated grief in other
population-based research [37]. Earlier analysis across
these countries found that poor home care also was as-
sociated with high formal care costs [19]. In contrast,
palliative care services had high quality, but were little
used, accounting for only 1–15% of formal care costs
[19]. Taken together, these findings suggest that improv-
ing community palliative care may improve care value,
the care experience for patients and ICrs; increase IC re-
wards; and reduce IC burden and formal care costs.
Treatments and interventions are ever more intricate,
especially in the face of a multimorbid, older person,
who is approaching the end of life [38, 39]. Co-
ordination between settings and between the diversity of
care interventions and treatments, communication and
the response of staff in the face of clinical uncertainty
collectively are vital to improve care experience, yet are
often lacking [40, 41]. As in the closely related field of
patient safely, consideration of the whole patient journey
is vital [42]. Our finding is particularly important at a
Table 3 Informal care (IC) costs and formal care costs of patients at the end of life in the last 3 months (US$)
Informal care costs I Informal care costs II* Formal care costs$ Percentage of total care costs that are informal care costs
Mean s.d. Median Mean s.d. Median Mean s.d. Informal care costs I Informal care costs II*
England 36,170 31,104 31,192 22,132 22,527 13,254 15,756 15,036 69.7% 58.4%
Ireland 43,760 36,930 36,398 26,767 25,477 18,604 29,210 24,231 60.0% 47.8%
USA 32,468 28,578 28,847 19,973 19,679 12,521 37,327 37,234 46.5% 34.9%
All countries 37,802 32,956 32,185 23,160 22,998 14,163 27,452 28,203 57.9% 45.8%
*Informal care cost II excludes the cost of “time spent ‘being on call’”
$Formal care costs were calculated by combining resource use data with unit costs obtained from standard as explained in [19]
Fig. 2 Relationship between subsequent grief and informal care (IC) costs in the last 3 months of older patient’s life in three countries. Note that
higher grief scores indicate ‘less’ grief
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Table 4 Factors associated with bereavement outcomes of carers who were identified as next of kin by older patients
Subsequent grief Burden Positive aspects
(1) (2) (3) (4) (5) (6)
Informal care cost ($1000)
β 0.06* 0.06* − 0.01 − 0.02 0.04* 0.03*
CIll 0.03 0.03 − 0.03 − 0.04 0.02 0.01
CIup 0.09 0.10 0.01 0.01 0.06 0.06
Age at death
β − 0.23* − 0.28* − 0.04 − 0.01 0.02 0.00
CIll − 0.35 − 0.42 − 0.13 − 0.11 − 0.06 − 0.07
CIup − 0.11 − 0.15 0.05 0.09 0.09 0.07
Cancer (= 1 if cancer)
β 0.54 0.14 − 0.73 − 0.24 1.08 1.01
CIll − 1.46 − 2.15 − 2.25 − 2.02 − 0.17 − 0.43
CIup 2.54 2.43 0.78 1.55 2.32 2.45
Formal care cost ($1000)
β 0.00 0.00 0.01 0.01 − 0.00 0.02
CIll − 0.03 − 0.05 − 0.01 − 0.02 − 0.02 − 0.00
CIup 0.04 0.05 0.03 0.05 0.02 0.05
Satisfaction with hospital care
β − 0.75** − 0.76** 0.23
CIll − 1.46 − 1.35 − 0.19
CIup − 0.05 − 0.17 0.65
Satisfaction with home care
β − 0.47 − 0.84* 0.66*
CIll − 1.24 − 1.47 0.22
CIup 0.29 − 0.22 1.10
Carer religious (= 1 if religious)
β 1.93 1.64 − 2.67** − 4.01* 1.60** 1.32
CIll − 0.71 − 1.22 − 4.78 − 6.46 0.04 − 0.35
CIup 4.58 4.50 − 0.57 − 1.55 3.15 2.98
Relationship to patient (base: wife)
Husband
β − 0.37 − 0.14 − 0.71 − 1.65 0.10 − 0.15
CIll − 3.54 − 3.88 − 2.94 − 4.25 − 1.99 − 2.58
CIup 2.80 3.61 1.53 0.96 2.19 2.27
Daughter
β 0.92 1.51 3.85* 3.21* 0.90 0.55
CIll − 1.54 − 1.25 1.97 1.11 − 0.74 − 1.28
CIup 3.38 4.27 5.74 5.30 2.54 2.38
Son
β − 6.42** − 3.92** 2.04 0.88 0.17 1.10
CIll − 9.51 − 7.34 − 0.61 − 2.07 − 1.88 − 1.13
CIup − 3.32 − 0.51 4.69 3.83 2.21 3.34
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Table 4 Factors associated with bereavement outcomes of carers who were identified as next of kin by older patients (Continued)
Subsequent grief Burden Positive aspects
(1) (2) (3) (4) (5) (6)
Female relative
β − 6.20** − 4.80 2.55 1.59 0.08 − 0.03
CIll − 10.65 − 10.11 − 0.44 − 2.11 − 2.24 − 2.82
CIup − 1.74 0.51 5.53 5.30 2.40 2.77
Male relative
β − 14.02** − 13.36* − 1.68 − 3.66 − 2.62 0.53
CIll − 20.06 − 21.99 − 5.45 − 8.80 − 6.22 − 3.14
CIup − 7.97 − 4.73 2.10 1.48 0.98 4.20
Others
β − 10.54** − 11.08* − 2.97 − 4.44** 1.24 2.01
CIll − 16.73 − 18.17 − 6.21 − 8.78 − 1.47 − 1.08
CIup − 4.34 − 3.98 0.28 − 0.09 3.96 5.10
Carer’s financial status (base: living comfortably)
Doing alright
β 1.84 0.12 0.22 0.41 0.38 0.69
CIll − 0.29 − 2.26 − 1.31 − 1.37 − 0.93 − 0.76
CIup 3.97 2.50 1.75 2.19 1.70 2.15
Just about getting by
β 3.94* 4.78* 1.38 3.15 − 0.50 − 0.64
CIll 0.95 1.16 − 0.92 0.36 − 2.35 − 2.94
CIup 6.94 8.39 3.68 5.94 1.35 1.67
Finding it quite difficult
β 7.91* 6.47* 3.06 3.72 − 2.05 − 0.74
CIll 4.38 2.99 − 0.16 0.43 − 4.47 − 3.11
CIup 11.44 9.95 6.28 7.01 0.37 1.63
Finding it very difficult
β 5.16 5.25 3.58 0.52 3.34 1.96
CIll − 6.31 − 10.48 − 1.24 − 4.73 − 1.71 − 2.84
CIup 16.63 20.98 8.40 5.78 8.39 6.75
Do not know
β 3.20 2.58 − 1.45 − 2.03 0.83 1.22
CIll − 1.54 − 3.83 − 5.04 − 7.17 − 2.03 − 2.38
CIup 7.95 8.99 2.14 3.12 3.69 4.83
Country (base: England)
Ireland
β 0.22 0.47 − 1.54 − 1.41 0.86 − 0.36
CIll − 2.13 − 2.23 − 3.29 − 3.47 − 0.59 − 1.99
CIup 2.58 3.17 0.22 0.65 2.30 1.26
USA
β − 0.97 − 3.00** 0.09 − 0.20 1.92** 0.76
CIll − 3.51 − 5.86 − 1.82 − 2.31 0.38 − 0.88
CIup 1.57 − 0.15 1.99 1.92 3.47 2.40
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time when carers are being asked to do more, due to
self- and family isolation for older people as a result of
the COVID-19 pandemic [43], including potentially to
administer medicines [44].
Interestingly, IC costs were quite similar between our
countries, in contrast to formal end of life care costs
which varied much more [19]. We found the contribu-
tion of ICrs in all three countries was similar in terms of
hours of care provided and types of support given. Most
studies of ICrs have considered the impacts on individ-
ual caregivers, rather than the needs of patients overall.
A UK survey of bereaved cancer carers (29% response)
found that respondents reported a median of 70 h of
caregiving each week [45]. However, a societal perspec-
tive to supporting end of life care requires that the con-
tribution of all caregivers be considered [46–48], as in
our study. We observed that patients received higher
levels of support, which is identified in earlier studies.
Patients were provided with 19–21 h of IC per week for
personal care, 15–18 h for medical procedures, 7–10 h
for appointments and 17–21 h for household tasks. ICrs
also spent 66–76 h per week on being on call and 52–55
h being with patients. Using the societal perspective
taken, our data suggest that IC costs at the end of life
(usually based on allocating a minimum wage to care-
giver’s activities) account for more than half of total
care costs. Out of pocket payment for medications
and private health insurance are not included in this
analysis, and so may slightly underestimate care costs.
However, we do not believe that this substantially al-
ters our findings. Payment for prescription medicines
varies between countries so would limit international
comparison. This descriptive data is an important
contribution, because end of life care lags behind
much of health care in economic appraisal [49]. We
were able to identify some tasks that would likely
need to be performed at a relatively fixed times of
day (such as medical procedures, personal care, ap-
pointments), and others (such as household tasks)
that may be adjustable and performed at other times
or even on different days, reducing the ‘time-bound’
opportunity costs [50].
We were surprised by the amount of time spent by
ICrs on call, this was the most common activity. It may
be that the uncertainties encountered in end of life care
[51–54] mean that ICrs felt that someone in the family
was on call most of the time. This will require a flexibil-
ity by employers to allow ICrs to be able to respond to
unpredictable needs. It also highlights the need for
effective out-of-hours palliative care, in all settings, to
support not only patients but caregivers, who are sup-
porting patients throughout much of the week, and, at
least in our study, anticipate problems outside ‘normal’
9–5 working hours.
We were also surprised by the lower numbers of
people with dementia in our study. However, this was a
sample of people who were recruited from primarily
hospital-based palliative care services, where people in
late stage dementia may have limited access. Dementia
may also have been under-represented in our data on
primary diagnosis and is sometimes missed. This war-
rants further study, and we have planned the Inter-
national, Access, Rights, and Empowerment II (IARE II),
to study older people with symptoms and frailty who are
not receiving specialist palliative care.
Strengths
We took a societal approach to costing, including IC
costs, which places greater recognition on the role of
ICrs. We were able to collect the same data across our
different countries, making the finding of similar pat-
terns, in contrast to formal care costs which varied more
between countries [19], more noteworthy and widely
generalisable. We also had data from four major cities,
all in the top ranks of the Global Power City Index:
rankings are as follows: London 1, Dublin 33, New York
2 and San Francisco 18 [55], Cities are becoming the
norm for many societies, and so our focus on cities
makes our findings highly relevant to care for the future.
We had a response similar to or better than similar mor-
tality follow-back surveys [16, 56]. We focussed on the
last 3 months of life, when it is known that formal care
costs increase especially [7–10].
Table 4 Factors associated with bereavement outcomes of carers who were identified as next of kin by older patients (Continued)
Subsequent grief Burden Positive aspects
(1) (2) (3) (4) (5) (6)
Constant
β 60.86* 64.11* 32.76* 32.32* 23.08* 22.67*
CIll 50.04 51.53 24.54 23.11 16.42 15.68
CIup 71.67 76.70 40.99 41.53 29.74 29.66
Observations 608 459 609 459 604 456
R-squared 0.26 0.27 0.11 0.15 0.07 0.07
Notes: * p < 0.05, ** p < 0.1. Models 1, 3 and 5 included carer’s satisfaction with care in hospital, and models 2, 4 and 6 included carer’s satisfaction with care at home
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Limitations
Our results are based on responses from bereaved carers
or next of kin; thus, we do not know the informal care
provided to patients who do not have such carers but
might have had support from neighbours, friends or rel-
atives missed by our survey. ICrs may have different per-
spectives from patients and may have recall bias about
the care provided, although the time window used in
our mortality follow-back survey, 4–10 months after be-
reavement, is usually considered optimal [16, 24]. Our
respondents were identified by the specialist palliative
care teams in participating hospitals which provided pal-
liative care services for the bereaved carers. ICrs of pa-
tients who did not have access to palliative care or
bereavement care may have different experiences, pos-
sibly worse. More than 80% of patients and ICrs
reported having a religious belief, which is higher than
might be expected. This may be due to sample or meas-
urement bias. We do not know whether or how ICrs
were practising beliefs. Thus, the results suggesting that
ICrs with a religious belief felt less burdened should be
treated with caution. We were not allowed under the
ethics approval to collect data on non-responders, so we
were not able to compare the characteristics of responders
and non-responders. There were some differences between
cities in their response rates, but the similarities between
countries in informal care activities do not suggest that this
altered our overall findings or conclusions. We asked about
total IC activities involving all members of the family and
friends, but the assessments of grief relate to the main ICrs,
and for practical reasons, we were not able to study grief
among all those involved in caregiving. The data are cross-
sectional, which limits the basis for establishing causality:
we cannot positively determine that increased IC costs pro-
tected against grief, nor that poor quality care resulted in
greater IC burden or fewer rewards. However, our findings
meet many of the Bradford-Hill criteria for supporting
causal relationships, such as consistency with other litera-
ture and across settings, temporality, plausibility and coher-
ence [57]. Further, in this complex situation of end of life
care, it is impossible to understand any causal chain per-
fectly, i.e. know every factor that could be considered a
cause [58, 59]. Even if the chain were clear, it would not be
clear how best to change the outcome, as the interventions
are by definition complex [18]. Our data provide insights
into how to improve care value at the end of life, which is
profoundly needed and can also help with the appropriate
modelling of complex interventions [18]. Our data may also
help with the development of robust business cases for
palliative care [60].
Conclusion
The contribution of ICrs is considerable, accounting for
around 50% of total care costs. These costs are similar
across countries. Training and support interventions for
ICrs should target the wide range of activities that they
undertake. Increased informal care hours and costs, can
lead to more rewards and lesser subsequent grief. There-
fore ICrs, including family and friends and beyond one
main informal carer, are central at the end of life and
should be considered in all interventions. Our finding of
an association between poor care quality and poorer
ICrs outcomes, including greater burden and fewer re-
wards, suggests an urgent need to improve care quality,
through the better integration and support for dedicated
community palliative care services, and support people
across the whole journey of care. Improving community
palliative care may improve care value, the care expe-
rience for patients and ICrs; increase IC rewards; and
reduce IC burden and formal care costs and should be a
focus for investment, including and importantly during
the COVID-19 pandemic.
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